This content is PDF only. Please click on the PDF icon to access.
The agent that causes human infectious hepatitis has not yet been identified but is presumed to be a virus. No vaccine is available. Administration of immune serum globulin (ISG)* to exposed persons can, however, afford a high degree of protection against infectious hepatitis. ISG substantially reduces the frequency of overt clinical disease, although inapparent infection may occur. After such infection, life-long active immunity is thought to develop.
Patients with infectious hepatitis have been shown to excrete virus in stool as much as 2 to 3 weeks before and 2 weeks after onset of jaundice. Viremia has been demonstrated
Immune Serum Globulin for Prevention of Viral Hepatitis: Recommendation on Immunizing Practices: Issued by the Advisory Committee on Immunizing Practices, U. S. Public Health Service, Meeting in June 1968.. Ann Intern Med. 1968;69:1009–1011. doi: https://doi.org/10.7326/0003-4819-69-5-1009
Download citation file:
Published: Ann Intern Med. 1968;69(5):1009-1011.
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Viral Hepatitis.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use